Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Trametinib sensitizes KRAS-mutant lung adenocarcinoma tumors to PD-1/PD-L1 axis blockade via Id1 downregulation.
Mol Cancer. 2024 Apr 20;23(1):78. doi: 10.1186/s12943-024-01991-3.
Mol Cancer. 2024.
PMID: 38643157
Free PMC article.
A novel [89Zr]-anti-PD-1-PET-CT to assess response to PD-1/PD-L1 blockade in lung cancer.
Puyalto A, Rodríguez-Remírez M, López I, Iribarren F, Simón JA, Ecay M, Collantes M, Vilalta-Lacarra A, Francisco-Cruz A, Solórzano JL, Sandiego S, Peñuelas I, Calvo A, Ajona D, Gil-Bazo I.
Puyalto A, et al. Among authors: vilalta lacarra a.
Front Immunol. 2023 Sep 28;14:1272570. doi: 10.3389/fimmu.2023.1272570. eCollection 2023.
Front Immunol. 2023.
PMID: 37841258
Free PMC article.
Item in Clipboard
Association of depression phenotypes and antidepressant treatment with mortality due to cancer and other causes: a community-based cohort study.
Vilalta-Lacarra A, Vilalta-Franch J, Serrano-Sarbosa D, Martí-Lluch R, Marrugat J, Garre-Olmo J.
Vilalta-Lacarra A, et al.
Front Psychol. 2023 Aug 24;14:1192462. doi: 10.3389/fpsyg.2023.1192462. eCollection 2023.
Front Psychol. 2023.
PMID: 37711322
Free PMC article.
Item in Clipboard
Therapeutic drug monitoring of neoadjuvant mFOLFIRINOX in resected pancreatic ductal adenocarcinoma.
Vilalta-Lacarra A, Aldaz A, Sala-Elarre P, Urrizola A, Chopitea A, Arbea L, Rotellar F, Pardo F, Martí-Cruchaga P, Zozaya G, Subtil JC, Rodríguez-Rodríguez J, Ponz-Sarvise M.
Vilalta-Lacarra A, et al.
Pancreatology. 2023 Jun;23(4):411-419. doi: 10.1016/j.pan.2023.03.001. Epub 2023 Mar 14.
Pancreatology. 2023.
PMID: 37169668
Free article.
Item in Clipboard
Integration of longitudinal deep-radiomics and clinical data improves the prediction of durable benefits to anti-PD-1/PD-L1 immunotherapy in advanced NSCLC patients.
Farina B, Guerra ADR, Bermejo-Peláez D, Miras CP, Peral AA, Madueño GG, Jaime JC, Vilalta-Lacarra A, Pérez JR, Muñoz-Barrutia A, Peces-Barba GR, Maceiras LS, Gil-Bazo I, Gómez MD, Ledesma-Carbayo MJ.
Farina B, et al. Among authors: vilalta lacarra a.
J Transl Med. 2023 Mar 5;21(1):174. doi: 10.1186/s12967-023-04004-x.
J Transl Med. 2023.
PMID: 36872371
Free PMC article.
Item in Clipboard
"What medical students with better academic results do: a cross-sectional analysis".
Urrizola A, Santiago R, Gea A, Rubio S, Vilalta-Lacarra A, Rodríguez J, Arbea L.
Urrizola A, et al. Among authors: vilalta lacarra a.
BMC Med Educ. 2023 Jan 11;23(1):19. doi: 10.1186/s12909-023-03999-7.
BMC Med Educ. 2023.
PMID: 36631815
Free PMC article.
Item in Clipboard
Impact on the Nutritional Status and Inflammation of Patients with Cancer Hospitalized after the SARS-CoV-2 Lockdown.
Yárnoz-Esquíroz P, Chopitea A, Olazarán L, Aguas-Ayesa M, Silva C, Vilalta-Lacarra A, Escalada J, Gil-Bazo I, Frühbeck G, Gómez-Ambrosi J.
Yárnoz-Esquíroz P, et al. Among authors: vilalta lacarra a.
Nutrients. 2022 Jul 2;14(13):2754. doi: 10.3390/nu14132754.
Nutrients. 2022.
PMID: 35807934
Free PMC article.
Item in Clipboard
[Thalamic infarction with disappearance of the clinical signs and symptoms of rheumatic fibromyalgia].
López-Pousa S, Vilanova JC, López-Ojeda P; Fibromialgia Research Group.
López-Pousa S, et al.
Rev Neurol. 2011 Dec 16;53(12):765-6.
Rev Neurol. 2011.
PMID: 22127664
Free article.
Spanish.
No abstract available.
Item in Clipboard
Cite
Cite